Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
IGG-PFY69 | Mouse | PE-Labeled Mouse-Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8) |
![]() ![]() |
||
IGG-BLY69 | Mouse | Biotinylated Monoclonal Mouse Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8) |
![]() ![]() |
![]() ![]() |
|
AHG-Y69 | Mouse | Anti-Human IgG Antibody-Acridinium ester (MALS verified) |
![]() ![]() |
||
IGG-LY69 | Mouse | HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8), mAb |
![]() ![]() |
Flow cytometric analysis of Anti-CD19 CAR-293 cells staining with 100 μL of 20 μg/mL Human CD19 (20-291) Protein, Fc Tag, low endotoxin (Cat. No. CD9-H5259) and negative control protein respectively, washed and then followed with PE-Labeled Mouse-Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8) (Cat. No. IGG-PFY69) at 1:50 dilution (2 μL of the antibody stock solution corresponds to labeling of 1e6 cells in a final volume of 100 µL) and analyzed with FACS. PE signal was used to evaluate the binding activity (QC tested).
Immobilized Human TNF-alpha Protein, His Tag (Cat. No. TNA-H5228) at 2 μg/mL (100 μL/well) can bind Human Monoclonal Anti-TNF-alpha antibody, Human IgG1 (16H5) (Cat. No. TNA-AM494) when detected by HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8),mAb (Cat. No. IGG-LY69) dilute at 1:10000 (0.0842μg/ml) (QC tested).
Immobilized Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (Cat. No. SPD-M265) at 1 μg/mL (100 μL/well) can bind Biotinylated Monoclonal Mouse Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8) (Cat. No. IGG-BLY69) with a linear range of 0.2-16 ng/mL (QC tested).
This web search service is supported by Google Inc.